These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 6462898

  • 21. Testing of new hypoxic cell sensitizers in vivo.
    Stone HB, Sinesi MS.
    Radiat Res; 1982 Jul; 91(1):186-98. PubMed ID: 6212963
    [No Abstract] [Full Text] [Related]

  • 22. Radiosensitization of a mouse tumour by Ro 03-8799: acute and protracted administration.
    Hill SA, Fowler JF, Minchinton AI, Stratford MR, Denekamp J.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1983 Aug; 44(2):143-50. PubMed ID: 6603435
    [Abstract] [Full Text] [Related]

  • 23. Enhanced tumor responses through therapies combining CCNU, MISO and radiation.
    Siemann DW, Hill SA.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1623-6. PubMed ID: 6480451
    [Abstract] [Full Text] [Related]

  • 24. The in vivo response of a C3H mammary carcinoma to treatment with misonidazole, cyclophosphamide and radiation.
    Grau C, Zachariae C, Mao HS, Overgaard J.
    Acta Oncol; 1990 Sep; 29(6):769-74. PubMed ID: 2223148
    [Abstract] [Full Text] [Related]

  • 25. Response of an experimental mammary carcinoma to fractionated X-irradiation with misonidazole and microwave hyperthermia.
    Goldfeder A, Brown DM.
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1287-91. PubMed ID: 6469752
    [Abstract] [Full Text] [Related]

  • 26. In vivo cytotoxicity of misonidazole and hyperthermia in a transplanted mouse mammary tumor.
    Lehman CM, Stewart JR.
    Radiat Res; 1983 Dec; 96(3):628-34. PubMed ID: 6657927
    [Abstract] [Full Text] [Related]

  • 27. Enhancement of the DNA cross-linking activity of nitrogen mustard by misonidazole and diethyl maleate in a mouse fibrosarcoma tumor in vivo.
    Murray D, Meyn RE.
    Cancer Res; 1984 Jan; 44(1):91-6. PubMed ID: 6690065
    [Abstract] [Full Text] [Related]

  • 28. Potentiation of combination chemotherapy by nitroheterocyclics.
    Siemann DW, Allalunis-Turner MJ.
    Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):129-34. PubMed ID: 3391809
    [Abstract] [Full Text] [Related]

  • 29. Oxygen cathode measurements and radiation response in tumour-bearing mice treated with misonidazole.
    Davies RW, Hall WS.
    Br J Cancer Suppl; 1978 Jun; 3():154-8. PubMed ID: 277216
    [Abstract] [Full Text] [Related]

  • 30. [Intensification of cytostatic action by radiosensitizers--a review of the present status of chemosensitization].
    Moldenhauer H, Rose H, Saul G, Wolf G, Kehrberg G.
    Radiobiol Radiother (Berl); 1984 Jun; 25(2):289-95. PubMed ID: 6234615
    [No Abstract] [Full Text] [Related]

  • 31. Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.
    McNally NJ, Hinchliffe M, de Ronde J.
    Br J Cancer; 1983 Aug; 48(2):271-8. PubMed ID: 6882665
    [Abstract] [Full Text] [Related]

  • 32. Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer.
    McNally NJ, Denekamp J, Sheldon P, Flockhart IR, Stewart FA.
    Radiat Res; 1978 Mar; 73(3):568-80. PubMed ID: 273269
    [No Abstract] [Full Text] [Related]

  • 33. Evaluation of [131I]iodoerythronitroimidazole as a predictor for the radiosensitizing effect.
    Inoue T, Yang DJ, Wallace S, Cherif A, Tansey W, Kim EE, Hunter N, Milross CG, Milas L, Podoloff DA.
    Anticancer Drugs; 1996 Nov; 7(8):858-65. PubMed ID: 8991190
    [Abstract] [Full Text] [Related]

  • 34. Relative efficacy of high-pressure oxygen and misonidazole to reduce TCD50 of a mouse mammary carcinoma.
    Suit HD, Brown JM.
    Br J Radiol; 1979 Feb; 52(614):159-60. PubMed ID: 427373
    [No Abstract] [Full Text] [Related]

  • 35. The demonstration of in vivo misonidazole tumour toxicity using post radiation hypoxia.
    Gomer CJ, Johnson RJ, Hetzel FW, Lawrence G.
    Br J Cancer Suppl; 1978 Jun; 3():228-31. PubMed ID: 277234
    [Abstract] [Full Text] [Related]

  • 36. Comparison of hyperbaric oxygen and misonidazole in fractionated irradiation of murine tumors.
    Suit HD, Maimonis P, Michaels HB, Sedlacek R.
    Radiat Res; 1981 Aug; 87(2):360-7. PubMed ID: 7268001
    [No Abstract] [Full Text] [Related]

  • 37. Enhancement of the DNA cross-linking activity of melphalan by misonidazole in vivo.
    Murray D, Meyn RE.
    Br J Cancer; 1983 Feb; 47(2):195-203. PubMed ID: 6824567
    [Abstract] [Full Text] [Related]

  • 38. Enhancement of radioresponse of a mouse mammary carcinoma to combined treatments with hyperthermia and radiosensitizer misonidazole.
    Goldfeder A, Brown DM, Berger A.
    Cancer Res; 1979 Aug; 39(8):2966-70. PubMed ID: 455281
    [Abstract] [Full Text] [Related]

  • 39. Radiosensitizing effect of combined radiotherapy, hyperthermia and misonidazole on C3H mouse FM3A tumor.
    Yamashita M.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Sep 25; 44(9):1181-8. PubMed ID: 6522270
    [No Abstract] [Full Text] [Related]

  • 40. Misonidazole cytotoxicity in vivo: a comparison of large single doses with smaller doses and extended contact of the drug with tumor cells.
    Conroy PJ, Sutherland RM, Passalacqua W.
    Radiat Res; 1980 Jul 25; 83(1):169-89. PubMed ID: 7394163
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.